Comparative effectiveness and safety of high ‐dose rivaroxaban and apixaban for atrial fibrillation: A propensity score‐matched cohort study

ConclusionIn this study, composite effectiveness and safety varied between rivaroxaban and apixaban. High ‐dose apixaban was observed to have a better effectiveness and safety.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - February 27, 2021 Category: Drugs & Pharmacology Authors: Sylvie Perreault, Alice Dragomir, Robert C ôté, Aurélie Lenglet, Brian White‐Guay, Simon Denus, Mireille E. Schnitzer, Marie‐Pierre Dubé, James M. Brophy, Marc Dorais, Jean‐Claude Tardif Tags: ORIGINAL RESEARCH ARTICLE Source Type: research